BD Neopak syringe

The BD Neopak™ syringe platform captures the essence of BD’s 30 year collaboration with biopharma industry, leveraged to best meet current and emerging requirements of sensitive biologic drugs for chronic disease patients. The BD Neopak™ platform has been developed with a goal to assure the most efficient combination of product development and commercialization.

The BD Neopak™ syringe is available in both 1-ml and 2.25 ml formats, and can be expanded to include BD Advanced Technologies such as BD XSi™, and BD VisioGuard™

Compatibility with sensitive biopharmaceuticals

The BD Neopak syringe offers unprecedented product performance starting with optimized compatibility with biopharmaceutical drugs through low tungsten as the standard and an ultralow tungsten option; reduced silicone quantity and an optimized gliding force; and improved glue curing to reduce leachables and extractables and their potential interaction with sensitive drugs.

Breakthrough manufacturing processes

BD has challenged each step of the manufacturing process to reach optimized product performance. From using premium materials to conducting a 100% camera inspection, we assure proven product quality and a modular line preventing all glass-to-glass contact.
BD Neopak manufacturing process is designed to meet your strictest quality requirements

– Overall specification tightening (>80%)
– No glass to glass or glass to metal contact
– Automated visual inspection control
– Significantly reduced eject rate

Quality by design approach – achieving Six Sigma-quality levels

Eighty percent of the specifications characterizing the BD Neopak syringe are new or significantly improved. This includes increased drug compatibility, breakage resistance, cosmetic quality, autoinjector compatibility and dimensional precision for optimized dose accuracy.

Conceived for superior autoinjector compatibility:

– Improved glass quality
– Improved dimensional precision
– Tightly controlled gliding performance

Opening the design space through a wide portfolio of options:

– Barrel size (1ml & 2.25ml)
– Needle gauges
– Needle shields formulation (4800 , FM30, BD260)
– Flange design (Cut Flange, Small Round Flange, Small Extra-round Flange)
– Autoinjector & Safety solutions

Certificate of Analysis

The certificate of analysis for the BD Neopak syringe allows delegation of control, helping streamline incoming inspections and reduce the associated costs.


Click here to download